Hezhi Fang

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Skeletal Muscle

Top Venues

Journal of molecular medicine (Berlin, Germany)

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Xiangshu Yuan, Ya Wang, Xiyuan Li, Sheng Zhong, Danyi Zhou, Xianlong Lin, Hezhi Fang, Yanling Yang, Maofeng Wang
Loss-of-function mutation in DDX53 associated with hereditary spastic paraplegia-like disorder. Journal of molecular medicine (Berlin, Germany) (2024)
Xiangshu Yuan, Ya Wang, Xiyuan Li, Sheng Zhong, Danyi Zhou, Xianlong Lin, Hezhi Fang, Yanling Yang, Maofeng Wang
Loss-of-function mutation in DDX53 associated with hereditary spastic paraplegia-like disorder. Journal of molecular medicine (Berlin, Germany) 102 (7) (2024)
Xiangshu Yuan, Ya Wang, Xiyuan Li, Sheng Zhong, Danyi Zhou, Xianlong Lin, Hezhi Fang, Yanling Yang, Maofeng Wang
Loss-of-function mutation in DDX53 associated with hereditary spastic paraplegia-like disorder. Journal of molecular medicine (Berlin, Germany) 102 (7) (2024)
Xianglai Ye, Yaojun Xie, Yu Shi, Bo Wang, Xinyu Han, Xiaoxuan Zhou, Kexin Pan, Maofeng Wang, Hezhi Fang
Switching ubiquitous and muscle-specific isoforms of mitochondrial respiratory complex IV in skeletal muscle fine-tunes complex IV activity. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (4) (2023)
Hezhi Fang, Anran Xie, Miaomiao Du, Xueyun Li, Kaiqiang Yang, Yinxu Fu, Xiangshu Yuan, Runxiao Fan, Weidong Yu, Zhuohua Zhou, Tiantian Sang, Ke Nie, Jin Li, Qiongya Zhao, Zhehui Chen, Yanling Yang, Chaoyang Hong, Jianxin Lyu
SERAC1 is a component of the mitochondrial serine transporter complex required for the maintenance of mitochondrial DNA. Science translational medicine 14 (634) (2022)
Sixi Chen, Xinzhu Bao, Hongzhi Chen, Manli Jia, Wen Li, Luyi Zhang, Runxiao Fan, Hezhi Fang, Liqin Jin
Thyroid Cancer-Associated Mitochondrial DNA Mutation G3842A Promotes Tumorigenicity via ROS-Mediated ERK1/2 Activation. Oxidative medicine and cellular longevity 2022 (2022)
Xiujuan Wei, Miaomiao Du, Dongxiao Li, Shumeng Wen, Jie Xie, Yuanyuan Li, Aolong Chen, Kun Zhang, Pu Xu, Manli Jia, Chaowei Wen, Huaibin Zhou, Jianxin Lyu, Yanling Yang, Hezhi Fang
Mutations in FASTKD2 are associated with mitochondrial disease with multi-OXPHOS deficiency. Human mutation 41 (5) (2020)
Hezhi Fang, Nianqi Hu, Qiongya Zhao, Bingqian Wang, Huaibin Zhou, Qingzi Fu, Lijun Shen, Xiong Chen, Feixia Shen, Jianxin Lyu
mtDNA Haplogroup N9a Increases the Risk of Type 2 Diabetes by Altering Mitochondrial Function and Intracellular Mitochondrial Signals. Diabetes 67 (7) (2018)
Lin Ma, Qingzi Fu, Bing Xu, Huaibin Zhou, Jing Gao, Xiaoli Shao, Jingting Xiong, Qianru Gu, Shumeng Wen, Fengjie Li, Lijun Shen, Guorong Chen, Hezhi Fang, Jianxin Lyu
Breast cancer-associated mitochondrial DNA haplogroup promotes neoplastic growth via ROS-mediated AKT activation. International journal of cancer 142 (9) (2017)
Huaibin Zhou, Ke Nie, Ruyi Qiu, Jingting Xiong, Xiaoli Shao, Bingqian Wang, Lijun Shen, Jianxin Lyu, Hezhi Fang
Generation and Bioenergetic Profiles of Cybrids with East Asian mtDNA Haplogroups. Oxidative medicine and cellular longevity 2017 (2017)